SCHEMBL31548979

SCHEMBL31548979

CCOC(=O)/C=C/c1cc(F)ccc1OC(=O)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.43
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
ESR1 P03372 1/20 0.40
PTGS2 P35354 1/20 0.39
FDPS P14324 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP3A4 P08684 2/20 0.38
POLB P06746 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
DPP4 P27487 2/20 0.38
TTR P02766 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23440887 0.85 HTT (0.43) TDO2CA1CA2KDM4ESMN1; SMN2
SCHEMBL23440876 0.79 PTGDR2 (0.40) KMT2ACHRM3ALDH1A1HPGDSMN1; SMN2
SCHEMBL29191491 0.77 PTGER4 (0.53) FDPSKDM4E
SCHEMBL2690713 0.77 FDPS (0.56) FBP1FDPSMEN1KMT2ADPP4
SCHEMBL5574666 0.77 FDPS (0.56) FBP1FDPSMEN1KMT2ADPP4
SCHEMBL31548998 0.74 SMN1; SMN2 (0.40) ESR1FDPSMEN1KMT2APOLB
SCHEMBL31390627 0.73 CYP3A4 (0.51) IDO1TDO2ESR1FDPSMEN1
SCHEMBL2325697 0.73 CYP3A4 (0.51) IDO1TDO2ESR1FDPSMEN1
SCHEMBL2325706 0.73 CYP3A4 (0.51) IDO1TDO2ESR1FDPSMEN1
SCHEMBL22078663 0.73 FBP1 (0.46) FBP1IDO1TDO2ESR1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188023-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2025-06-12 US disclosed
US-12258308-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2025-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258308-B2 Benzene derivative PMP22, TMBIM6, MYT1 FBP1 627/4885IDO1 3391/4885TDO2 3399/4885
US-20250188023-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 FBP1 652/4885IDO1 3381/4885TDO2 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.